July 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teladoc Health, Inc. (“Teladoc Health” or “the Company”) (NYSE: TDOC). Investors who purchased Teladoc Health securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Teladoc… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alnylam Pharmaceuticals, Inc. (“Alnylam” or “the Company”) (NASDAQ: ALNY). Investors who purchased Alnylam securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alnylam has violated… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of O-I Glass, Inc. (“O-I Glass” or “the Company”) (NYSE: OI). Investors who purchased O-I Glass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether O-I… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phathom Pharmaceuticals, Inc. (“Phathom” or “the Company”) (NASDAQ: PHAT). Investors who purchased Phathom securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phathom has violated… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS). Investors who purchased Hims & Hers securities are encouraged to obtain additional information and assist the investigation. The… read more
July 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Americold Realty Trust, Inc. (“Americold” or “the Company”) (NYSE: COLD). Investors who purchased Americold securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Americold has… read more
July 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group Inc. (“Replimune” or “the Company”) (NASDAQ: REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Replimune has violated… read more
July 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. (“ADTRAN” or “the Company”) (NASDAQ: ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ADTRAN has violated… read more
July 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s Laboratories” or “the Company”) (NYSE: RDY). Investors who purchased Dr. Reddy’s Laboratories securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
July 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. (“Agios” or “the Company”) (NASDAQ: AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agios has violated… read more
July 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zevra Therapeutics, Inc. (“Zevra” or “the Company”) (NASDAQ: ZVRA). Investors who purchased Zevra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zevra has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MapLight Therapeutics, Inc. (“MapLight” or “the Company”) (NASDAQ: MPLT). Investors who purchased MapLight securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MapLight has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pathward Financial, Inc. (“Pathward” or “the Company”) (NASDAQ: CASH). Investors who purchased Pathward securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pathward has violated… read more
July 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rollins, Inc. (“Rollins” or “the Company”) (NYSE: ROL). Investors who purchased Rollins securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rollins has violated federal… read more
July 23, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. (“Alignment” or “the Company”) (NASDAQ: ALHC). Investors who purchased Alignment securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alignment has violated… read more
July 22, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HDFC Bank Limited (“HDFC Bank” or “the Company”) (NYSE: HDB). Investors who purchased HDFC Bank securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HDFC… read more
July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telefonaktiebolaget LM Ericsson (“Ericsson” or “the Company”) (NASDAQ: ERIC). Investors who purchased Ericsson securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ericsson has violated… read more
July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the proposed take-private acquisition of Distribution Solutions Group, Inc. (NASDAQ: DSGR) by newly formed entities controlled by LKCM Headwater Investments, LLC to determine whether the transaction is fair to DSG’s unaffiliated shareholders and whether DSG’s Special Committee and… read more
July 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphabet Inc. (“Alphabet” or “the Company”) (NASDAQ: GOOG). Investors who purchased Alphabet securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alphabet has violated federal… read more
July 17, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celcuity Inc. (“Celcuity” or “the Company”) (NASDAQ: CELC). Investors who purchased Celcuity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Celcuity has violated federal… read more
July 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FirstSun Capital Bancorp (“FirstSun” or “the Company”) (NASDAQ: FSUN). Investors who purchased FirstSun securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether FirstSun has violated… read more
July 15, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HCA Healthcare, Inc. (“HCA” or “the Company”) (NYSE: HCA). Investors who purchased HCA securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HCA has violated… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AppLovin Corporation (“AppLovin” or “the Company”) (NASDAQ: APP). Investors who purchased AppLovin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AppLovin has violated federal… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of International Business Machines Corporation (“IBM” or “the Company”) (NYSE: IBM). Investors who purchased IBM securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IBM has… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AstraZeneca PLC (“AstraZeneca” or “the Company”) (NYSE: AZN). Investors who purchased AstraZeneca securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether AstraZeneca has violated federal… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ionis Pharmaceuticals, Inc. (“Ionis” or “the Company”) (NASDAQ: IONS). Investors who purchased Ionis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ionis has violated… read more
July 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities prior to March 30, 2026, and continue to hold to the present, are encouraged to obtain additional information… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snowflake Inc. (“Snowflake Inc.” or “the Company”) (NYSE: SNOW). Investors who purchased Snowflake Inc. securities prior to June 27, 2023, and continue to hold to the present, are encouraged to obtain… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin Covey Co. (“Franklin Covey” or “the Company”) (NYSE: FC). Investors who purchased Franklin Covey securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Franklin… read more
July 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solstice Advanced Materials, Inc. (“Solstice” or “the Company”) (NASDAQ: SOLS). Investors who purchased Solstice securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Solstice has… read more